Anteris Technologies Global (NASDAQ:AVR) Given New $9.00 Price Target at Barclays

Anteris Technologies Global (NASDAQ:AVR – Get Free Report) had its price target dropped by equities research analysts at Barclays from $10.00 to $9.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price target indicates a potential upside of 62.45% from the stock’s current price.

AVR has been the topic of several other research reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Wednesday, August 26th. Cantor Fitzgerald restated an “overweight” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research note on Wednesday, October 14th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Anteris Technologies Global currently has a consensus rating of “Hold” and an average target price of $13.75.

View Our Latest Stock Report on Anteris Technologies Global

Anteris Technologies Global Stock Performance

Shares of NASDAQ:AVR traded down $0.32 during trading hours on Friday, reaching $5.54. The stock had a trading volume of 172,397 shares, compared to its average volume of 1,153,564. Anteris Technologies Global has a 1 year low of $3.30 and a 1 year high of $11.06. The firm’s 50 day moving average is $7.03 and its 200-day moving average is $7.38. The stock has a market capitalization of $540.09 million, a price-to-earnings ratio of -3.46 and a beta of 2.02.

Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last released its quarterly earnings data on Tuesday, November 10th. The company reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.03. The business had revenue of $0.52 million during the quarter, compared to analysts’ expectations of $2.75 million. Anteris Technologies Global had a negative net margin of 4,637.48% and a negative return on equity of 57.15%. Analysts forecast that Anteris Technologies Global will post -1.21 EPS for the current year.

Insiders Place Their Bets

In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd purchased 272,695 shares of the stock in a transaction that occurred on Tuesday, October 6th. The stock was purchased at an average cost of $7.18 per share, with a total value of $1,957,950.10. Following the completion of the acquisition, the insider directly owned 6,358,271 shares of the company’s stock, valued at $45,652,385.78. This trade represents a 4.48% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders purchased a total of 1,554,730 shares of company stock worth $11,694,513 in the last three months. 4.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Anteris Technologies Global

Several hedge funds have recently added to or reduced their stakes in the stock. Greenline Wealth Management LLC purchased a new position in shares of Anteris Technologies Global in the 3rd quarter valued at $88,000. Russell Investments Group Ltd. raised its stake in Anteris Technologies Global by 18.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 30,472 shares of the company’s stock worth $237,000 after acquiring an additional 4,736 shares in the last quarter. Kestra Advisory Services LLC purchased a new stake in Anteris Technologies Global in the third quarter valued at $93,000. Forum Financial Management LP lifted its position in Anteris Technologies Global by 266.1% in the third quarter. Forum Financial Management LP now owns 40,008 shares of the company’s stock valued at $311,000 after acquiring an additional 29,081 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its position in Anteris Technologies Global by 26,789.3% in the third quarter. Farther Finance Advisors LLC now owns 15,058 shares of the company’s stock valued at $117,000 after acquiring an additional 15,002 shares during the last quarter.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global is a medical technology company focused on developing treatments for structural heart disease, particularly aortic valve conditions. Its work centers on transcatheter heart valve technology, which is designed to replace a damaged valve through a minimally invasive procedure. The company’s lead product is the DurAVR transcatheter heart valve. It is made using Anteris’ ADAPT tissue technology, which processes bovine pericardial tissue for use in medical devices. The valve is designed to resemble the structure and function of a healthy aortic valve.

Further Reading

Analyst Recommendations for Anteris Technologies Global (NASDAQ:AVR)

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.